CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 50 enrolled
Drug / intervention
Trandolapril 4 mg Tablets +1 moredrug
Likely dose
Trandolapril 4 mg Tabletsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00840073
NCT00840073Phase 1Completed
CompareCT.gov

A Single-Dose, Comparative Bioavailability Study of Two Formulations of Trandolapril 4 mg Tablets Under Fed Conditions.

Teva Pharmaceuticals USA·interventional·Posted Feb 10, 2009·Updated Aug 20, 2024

In Brief

A Phase 1 clinical trial evaluating Trandolapril 4 mg Tablets and Mavik® 4 mg Tablets for Healthy. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the comparative bioavailability between trandolapril 4 mg tablets (test) and Mavik® 4 mg Tablets (reference) after a single-dose in healthy subjects under fed conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
Collaborators--

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 10, 2009
Enrollment StartOct 1, 2004
Primary CompletionNov 1, 2004
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.4 years ago

Interventions

Trandolapril 4 mg Tabletsdrug

1 x 4 mg, single-dose fed

Mavik® 4 mg Tabletsdrug

1 x 4 mg, single-dose fed